Johnson & Johnson Furnishes Update on Ovarian Talc Litigation Resolution
Summary
Johnson & Johnson announced on July 27, 2026, an agreement for a comprehensive resolution of the ovarian talc litigation with leading plaintiff firms (via Ex. 99.1 press release). The agreement involves a $5.5 billion commitment by the Company, conditioned on the express participation of at least 95% of the remaining claims. The first payment, not exceeding $3 billion, is due in 2027, with no additional payments before 2028. This resolution follows a favorable Multi-District Litigation court causation ruling and aims to eliminate expenses associated with litigating the remaining 76,000 ovarian talc claims.
Why It Matters
This agreement for a $5.5 billion commitment to resolve the ovarian talc litigation is a highly material event, as it addresses significant legal exposure and aims to eliminate future litigation expenses for 76,000 claims, providing greater financial certainty for investors.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how JNJ traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View JNJ Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000200406
- Filing Date
- Tuesday, July 28, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- positive